TRIANGLE PHARMACEUTICALS INC
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: TRIANGLE PHARMACEUTICALS INC, 10-Q, EX-10.4, 2000-11-14
Next: NOVATEL WIRELESS INC, S-1/A, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains consolidated summary financial information extracted from
this quarterly report on Form 10-Q for the period ended September 30, 2000 and
is qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                  JAN-1-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                          20,470,000
<SECURITIES>                                    57,848,000
<RECEIVABLES>                                            0
<ALLOWANCES>                                             0
<INVENTORY>                                              0
<CURRENT-ASSETS>                                80,055,000
<PP&E>                                           9,726,000
<DEPRECIATION>                                  (3,791,000)
<TOTAL-ASSETS>                                  98,235,000
<CURRENT-LIABILITIES>                           40,863,000
<BONDS>                                                  0
                                    0
                                              0
<COMMON>                                            38,000
<OTHER-SE>                                      38,147,000
<TOTAL-LIABILITY-AND-EQUITY>                    98,235,000
<SALES>                                                  0
<TOTAL-REVENUES>                                 5,550,000
<CGS>                                                    0
<TOTAL-COSTS>                                            0
<OTHER-EXPENSES>                                95,744,000
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                       0
<INCOME-PRETAX>                                (84,200,000)
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                            (84,200,000)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                   (84,200,000)
<EPS-BASIC>                                          (2.21)
<EPS-DILUTED>                                        (2.21)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission